neurovax

The Immune Response Corporation to Present at EQUITIES Magazine ...
Business Wire (press release) - San Francisco,CA,USA
... Dr. O'Neill's presentation will include updates on advances in the clinical programs of IRC's two lead immune-based therapies: NeuroVax(TM) for multiple ...
See all stories on this topic

neurovax

CEOs of the American Stock Exchange, London Stock Exchange, Borsa ...
Market Wire (press release) - USA
... The Immune Response Corp. (OTCBB: IMNR) Carlsbad, CA -- is developing its lead immune-based therapeutic candidates: NeuroVax ™ targeting multiple ...
See all stories on this topic

---

tysabri

TODAY ON PHARMALIVE.COM
PharmaLive.com (press release) - Newtown,PA,USA
... R), Oxycontin(R) and Zithromax(R), the effects of competition on Copaxone(R) sales, including as a result of the expected reintroduction of Tysabri(R) into the ...

Restrictions Curb Use of Powerful Acne Drug
Wall Street Journal (subscription) - New York,NY,USA
... risk-management programs are reserved for drugs that are administered in hospitals or doctors' offices, such as the multiple sclerosis drug Tysabri, or certain ...